The National Institutes of Health (NIH) explains, GLP-1 (Glucagon-Like Peptide-1) is a hormone that regulates blood sugar and appetite by triggering insulin release and slowing digestion, creating lasting fullness. 1 GLP-1 receptors are present throughout the body, including the brain, GI tract, and pancreas
Pregnancy, breastfeeding, surgery, low-carbohydrate dieting, and prolonged fasting should also be discussed with a qualified professional
Studies show that individuals on semaglutide often lose around 15 percent of their starting weight, while tirzepatide can lead to reductions of 20 percent or more
Staying attuned to shifting consumer preferences will be critical to remain competitive in the weight management sector
Although food can slightly influence GLP-1 activity through high fiber and healthy-fat diets, supplements are unable to match the metabolic effect of these medications
Frequently Asked Questions Is semaglutide approved for everyone